Gefitinib in combination with prednisolone to avoid interstitial lung disease during non-small cell lung cancer treatment: A case report

Author：                  

Publisher： Spandidos Publications

ISSN： 1792-1074

Source： Oncology Letters, Vol.5, Iss.5, 2013-01, pp. : 1599-1600

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Successful treatment of EGFR-mutated non-small cell lung cancer with reduced-dose gefitinib: A case report

By              

Experimental and Therapeutic Medicine, Vol. 10, Iss. 1, 2015-01 ,pp. : 386-388

Spandidos Publications

Access to resources Recommend Favorite

Phase II combination of gefitinib and docetaxel for advanced or metastatic non-small cell lung cancer: clinical results and biological monitoring

By Gatineau M.  

Targeted Oncology, Vol. 1, Iss. 3, 2006-07 ,pp. : 114-122

Springer Publishing Company

Access to resources Recommend Favorite

Gefitinib-induced intestinal obstruction in advanced non-small cell lung carcinoma: A case report

By Liang YiChen   Wu Gang   Cheng Jing   Yu DanDan   Wu HongGe  

Oncology Letters, Vol. 10, Iss. 3, 2015-09 ,pp. : 1277-1280

Spandidos Publications

Access to resources Recommend Favorite

Gemcitabine plus oxaliplatin for the treatment of leptomeningeal metastases of non-small cell lung cancer: A case report and review of the literature

By            

Oncology Letters, Vol. 5, Iss. 5, 2013-01 ,pp. : 1559-1561

Spandidos Publications

Access to resources Recommend Favorite

Chemotherapy for non-small cell lung cancer complicated by idiopathic interstitial pneumonia

By                          

Oncology Letters, Vol. 4, Iss. 3, 2012-01 ,pp. : 477-482

Spandidos Publications

Access to resources Recommend Favorite